Shincort Dosage & Drug Information

Indications/Uses

RA, synovitis, allergic rhinitis, asthma, allergic dermatitis, pemphigus, allergic & inflammatory ophth diseases.

Dosage/Direction for Use

IM inj Adult & childn >12 yr Initially 60 mg intragluteally, adjusted to 40-80 mg, Childn 6-12 yr Initially 40 mg. IA or IB inj Small areas: Up to 10 mg; large joints: Up to 40 mg; multiple locus involvement: Up to 80 mg.

Contraindications

Acute psychoses, ocular herpes simplex, serious fungal or viral infections, TB meningitis. Myasthenia gravis, metastatic carcinoma, diverticulitis, fresh intestinal anastomoses, active or latent peptic ulcer, chronic nephritis, HTN, thromboembolic tendencies, osteoporosis, DM, psychotic tendencies, acute or chronic infections. Renal impairment.

Special Precautions

Not for IV administration. Prolonged therapy. Pregnancy.

Adverse Reactions

Transient pain, local irritation, atrophy & depigmentation at inj site, joint discomfort.

View ADR Reporting Link

Drug Interactions

Concomitant use w/ NSAIDs, pancuronium, insulin, oral hypoglycaemic agents, salicylates.

MIMS Class

Corticosteroid Hormones

ATC Classification

H02AB08 - triamcinolone ; Belongs to the class of glucocorticoids. Used in systemic corticosteroid preparations.

Regulatory Classification

B

Presentation/Packing

Form

Shincort inj 10 mg/mL

Packing/Price

5 mL x 10 × 1's

Form

Shincort inj 40 mg/mL

Packing/Price

1 mL x 100 × 1's;5 mL x 10 × 1's

Shincort

triamcinolone acetonide

Manufacturer:

Y.S.P. Industries

Distributor:

Y.S.P. Industries